Tag: dyskinesia

UK charity gives US biotech $1m for Parkinson’s research

by Selina McKee | Jan 25, 2018 | News | 0

UK charity Parkinson’s UK is handing over more than $1 million in funding to US biotech company Neurolixis, to help fuel development of a novel, experimental therapy for patients with Parkinson’s disease.

FDA OK’s first novel treatment for Parkinson’s in ten years

by Selina McKee | Mar 22, 2017 | News | 0

The US Food and Drug Administration has approved the first novel treatment option in more than a decade for patients with Parkinson’s disease experiencing ‘off’ episodes while being treated with levodopa/carbidopa.